back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-16 17:03 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+4,000,000 vol $0.05 each |
18,000,000 | |
| Filed 2025-03-18 17:31 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,759
+179,328 vol $0.06 each |
1,000,000 | |
| Filed 2025-03-18 17:30 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,509
+191,817 vol $0.06 each |
820,672 | |
| Filed 2025-03-18 17:29 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,893
+118,855 vol $0.058 each |
628,855 | |
| Filed 2025-03-18 17:29 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+10,000 vol $0.054 each |
510,000 | |
| Filed 2024-11-12 11:00 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,200
+100,000 vol $0.122 each |
500,000 | |
| Filed 2024-09-05 14:54 Tx date 2024-09-05 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+100,000 vol $0.125 each |
400,000 | |
| Filed 2024-05-13 17:33 Tx date 2024-05-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,199
+100,000 vol $0.142 each |
300,000 | |
| Filed 2023-11-17 16:55 Tx date 2023-11-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,600
+100,000 vol $0.166 each |
200,000 | |
| Filed 2023-05-26 14:48 Tx date 2023-05-26 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,080
+100,000 vol $0.1908 each |
100,000 | |
| Filed 2022-10-06 10:15 Tx date 2022-10-04 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$880,000
+4,000,000 vol $0.22 each |
14,000,000 | |
| Filed 2021-10-07 17:35 Tx date 2021-10-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,000,000 | ||
| Filed 2021-10-07 17:34 Tx date 2021-10-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|